Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -847.90% is 215% below its 5-year average of -269.36%, near the low end of its 5-year range (-847.90%–66.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 155.02% below its 12-month average of -332.48%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -847.90%.
RETURN ON EQUITY (ROE)
-847.90%
RETURN ON EQUITY (ROE) AVG TTM
-332.48%
RETURN ON EQUITY (ROE) AVG 3Y
-283.68%
RETURN ON EQUITY (ROE) AVG 5Y
-269.36%
RETURN ON EQUITY (ROE) AVG 10Y
-119.24%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-155.02%
CURRENT VS 3Y AVG
-198.89%
CURRENT VS 5Y AVG
-214.78%
CURRENT VS 10Y AVG
-611.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-1918.33%
vs the sector median at left
Exicure, Inc.
Market Cap
$6.88M
Return on Equity (ROE)
-847.90%
TTM Avg
-332.48%
3Y Avg
-283.68%
5Y Avg
-269.36%
Market Cap
$6.74M
Return on Equity (ROE)
-227.37%
TTM Avg
-118.13%
3Y Avg
-87.25%
5Y Avg
-55.09%
Market Cap
$7.04M
Return on Equity (ROE)
-111.46%
TTM Avg
-348.97%
3Y Avg
-374.13%
5Y Avg
-408.25%
Market Cap
$7.07M
Return on Equity (ROE)
-218.65%
TTM Avg
-54.74%
3Y Avg
-35.36%
5Y Avg
-35.36%
Market Cap
$7.12M
Return on Equity (ROE)
N/A
TTM Avg
-159.14%
3Y Avg
523.81%
5Y Avg
82.41%
Market Cap
$7.15M
Return on Equity (ROE)
-225.67%
TTM Avg
-236.53%
3Y Avg
-220.64%
5Y Avg
-186.37%
Market Cap
$6.61M
Return on Equity (ROE)
-143.54%
TTM Avg
-132.34%
3Y Avg
-104.07%
5Y Avg
-91.90%
Market Cap
$6.60M
Return on Equity (ROE)
N/A
TTM Avg
-266.00%
3Y Avg
851.50%
5Y Avg
629.05%
Market Cap
$6.60M
Return on Equity (ROE)
-54.09%
TTM Avg
-388.62%
3Y Avg
-105.04%
5Y Avg
-44.72%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exicure, Inc. (XCUR) | $6.88M | -847.90% | -332.48% | -283.68% | -269.36% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | -227.37% | -118.13% | -87.25% | -55.09% |
| KALA BIO, Inc. (KALA)vs › | $7.04M | -111.46% | -348.97% | -374.13% | -408.25% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | -218.65% | -54.74% | -35.36% | -35.36% |
| Skye Bioscience, Inc. (SKYE)vs › | $7.12M | N/A | -159.14% | 523.81% | 82.41% |
| Longeveron Inc. (LGVN)vs › | $7.15M | -225.67% | -236.53% | -220.64% | -186.37% |
| Biomerica, Inc. (BMRA)vs › | $6.61M | -143.54% | -132.34% | -104.07% | -91.90% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.60M | N/A | -266.00% | 851.50% | 629.05% |
| Aclarion, Inc. (ACON)vs › | $6.60M | -54.09% | -388.62% | -105.04% | -44.72% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.58M | -108.00% | -445.77% | -254.63% | -239.85% |
ROE
-847.9%
ROA
-72.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -847.90% |
| 2026-03-31 | -466.35% |
| 2025-12-31 | -125.98% |
| 2025-09-30 | -133.23% |
| 2025-06-30 | -88.94% |
| 2025-03-31 | -51.50% |
| 2024-12-31 | -143.25% |
| 2024-09-30 | -259.35% |
| 2024-06-30 | -506.63% |
| 2024-03-31 | -604.26% |
| 2023-12-31 | -558.03% |
| 2023-09-30 | 66.01% |
| 2023-06-30 | 31.58% |
| 2023-03-31 | 9.30% |
| 2022-12-31 | -17.30% |
| 2021-12-31 | -570.71% |
| 2021-09-30 | -450.28% |
| 2021-06-30 | -131.69% |
| 2021-03-31 | -76.53% |
| 2020-12-31 | -40.11% |
| 2020-09-30 | -29.91% |
| 2020-06-30 | -23.19% |
| 2020-03-31 | -23.34% |
| 2019-12-31 | -32.57% |
| 2019-09-30 | -32.45% |
| 2019-06-30 | -180.71% |
| 2019-03-31 | -137.36% |
| 2018-12-31 | -106.97% |
| 2018-09-30 | -82.39% |
| 2018-06-30 | -175.40% |
| 2018-03-31 | -82.95% |
| 2017-12-31 | -53.42% |
| 2017-09-30 | -113.08% |
| 2016-12-31 | -692.03% |
